“We are thrilled to enter this next phase of EvolutionIQ’s growth as part of the CCC team,” said Michael Saltzman, co-founder and co-CEO of EvolutionIQ. He emphasized that their team has created “category-creating technology” that delivers significant value to carrier customers, policyholders, and claimants by facilitating faster returns to health.
Jonathan Lewin, EvolutionIQ’s other co-founder and co-CEO, echoed these sentiments. “CCC and EvolutionIQ share a common focus on customers and the need to bring solutions to market that empower more compassionate support of claimants managing their recovery.”
CCC Authorizes $300M Share Repurchase Program
In tandem with the announcement of the acquisition, CCC’s board authorized a $300 million share repurchase program.
Legal Representation
Kirkland & Ellis LLP is advising CCC on the deal, with a team including corporate partners Will Boothby, Michael Chung, and Doug Ryder, along with capital markets partner Ross Leff. Details regarding Lowenstein Sandler LLP’s representation of EvolutionIQ were not immediately available.
